跳到主要內容區塊
細胞治療與再生醫學中心 Regenerative medicine committee
:::快捷選單
icon網路掛號 icon看診進度 icon即時動態 衛教專區 icon服務諮詢 icon交通指南 icon健康檢查 icon常見問答 該看哪一科
:::細胞治療與再生醫學中心 > Introduction

Introduction

引用 (5)
圖片
更新日期 2024/5/20 9:11:09
點閱 983
​Cell Therapy and Regenerative Medicine at TCVGH

team

Center Overview
        Our team consists of 40 physicians who specialize in cancer, autoimmune diseases, cardiac, neuronal and joint degenerative diseases. Currently, the CTRM focuses on cancer, amyotrophic lateral sclerosis (ALS), cerebral palsy, Alzheimer's disease, idiopathic pulmonary fibrosis, refractory lupus erythematosus, hypoxic encephalopathy as well as other difficult diseases.
        In addition to providing cell therapy, we also offer a range of interdisciplinary centers to bring patients the most comprehensive health care and service.
Our mission is to translate stem cells and cancer-fighting cells from the bench to bedside, providing new treatment options for those with cancer or chronic diseases who have failed conventional therapies. We have established in-house core teams of scientists and clinicians to build new cell processing laboratories and cGMP cell manufacturing laboratory to provide clinical-grade novel cell products through collaboration with universities and industry.

Services & Treatment
  • We provide integrated multidisciplinary care for cell therapy and immunotherapy.
  • We offer various adoptive cell therapies for stage IV cancer patients, including cytokine-induced killer cells (CIK), natural killer cells (NK), and dendritic cells (DC).
  • We offer Chimeric Antigen Receptor T cells (CAR-T) Therapy for refractory and relapsed acute B-cell leukemia and lymphoma.
  • We offer Adipocyte Derived Stem Cells (ADSCs) for Osteoarthritis and knee joint cartilage defect.
Clinical Trials
  • Allogenic mesenchymal stem cells for Cerebral palsy
  • Allogenic mesenchymal stem cells for Idiopathic pulmonary fibrosis
  • VEGF-engineered mesenchymal stem cells for Critical limb ischemia.
  • Anti-CD3 / anti-EGFR bispecific antibody-armed T cells for metastatic colorectal cancer .
  • Adoptive memory T cell therapy for hepatocellular carcinoma.
  • NY-eso-1 TCR-T therapy for solid tumors. 
  • Chimeric Antigen Receptor T cells (CAR-T) Therapy for refractory systemic lupus erythrematosus.
  • Chimeric Antigen Receptor T cells (CAR-T) Therapy for refractory lymphoma.
TAIWAN TCVGH Research Buliding R208
Tel +886-4-23592525 # 3998

回頂端